Allarity Therapeutics, Inc. Investing Cash Flow
Allarity Therapeutics, Inc. (ALLR) reported Investing Cash Flow of -$64.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- Allarity Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- Allarity Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$64.00K.
- Allarity Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00.
- Allarity Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $0.00.
- Allarity Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$8.00K.
- Allarity Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$298.00K.
- Allarity Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Allarity Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $791.00K, a 21.29% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$64.00K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$64.00K 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | -$8.00K 10-K · filed 2026-03-30 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | ||||
| 2024-12-31 | -$298.00K 10-K · filed 2026-03-30 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | ||||
| 2022-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$18.00K derived: sum of 2 quarters · filed 2024-03-08 | -$18.00K derived: sum of 3 quarters · filed 2024-03-08 | $791.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $809.00K 10-Q · filed 2023-11-14 | $814.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $809.00K 10-Q · filed 2023-08-14 | $814.00K derived: sum of 3 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $809.00K 10-Q · filed 2023-05-11 | $814.00K derived: sum of 2 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $1.00M 10-K · filed 2023-03-13 | $1.00M 10-K · filed 2022-05-17 | ||
| 2021-09-30 | $1.00M 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | -$3.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |